Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer Patients

Recruiting now

Conditions studied: Cancer

In brief

Our central hypothesis is that patient response to treatment, evaluated by full spectrum of outcome measures including tumor control, survival, toxicity, and quality of life (QoL), will correlate with biomarker expressions, which can be tested in the blood, other body fluid, imaging as well as tumor tissue (if available).

Key facts

Study ID

NCT05061342

Run by

Fengming Kong

People needed

5000

Starts

2019-06-27

Expected to finish

2029-12-31

Last updated by the study team

2026-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Cancer Patients
• 18 years of age and older.
• Scheduled to receive any kind of therapy in our center.
• Performance status of ECOG 0, 1, 2, or 3.
• Able to understand QoL questionnaire.
• Normal (non cancer) controls
• 18 years of age and older healthy volunteers.
• Without a history of cancer except for cured skin cancer, without any active cancer.
• ECOG Performance status 0, 1, 2, or 3.

You may not qualify if…

• Participants who have supposedly limited ability to complete the survey questionnaires of the present study will be excluded.

Where it is running

• UHongKongShenzhen — Shenzhen, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.